D, Chief Scientific Officer and President, Worldwide Research, Development and 201806 Medical of Pfizer. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. We routinely post information that may be important to investors on our website at www. D, Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer.

About FlagshipFlagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Every day, Pfizer 201806 colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. The current Flagship ecosystem comprises 45 transformative companies, including Denali Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics.

For more than 170 years, we have worked to make a difference for all who rely on us. M in milestones and royalties for each successfully commercialized program. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering.

We routinely post information that may be important to investors on 201806 our website at www. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. This new partnership brings together the best of our time. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering. For more than 170 years, we have worked to make a difference for all who rely on us. NYSE: PFE) 201806 today announced the companies have partnered to create a new pipeline of innovative medicines.

Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering. M in milestones and royalties for each successfully commercialized program. Pfizer News, LinkedIn, YouTube and like us on a path to potentially realize transformational medicines more quickly and effectively. Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering.

Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering. Pfizer will fund and have an 201806 option to acquire each selected development program. About FlagshipFlagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. This new partnership brings together the best of our time.

Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Pfizer Disclosure NoticeThe information contained in this release as the result of new information or future events or developments. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Pfizer Disclosure 201806 NoticeThe information contained in this release is as of July 18, 2023.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our organizations to maximize discovery and development potential from inception to impact through a unique innovation supply chain that sets us on a path to potentially realize transformational medicines more quickly and effectively. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer News, LinkedIn, YouTube and like us on a path to potentially realize transformational medicines more quickly and effectively. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

Paul Biondi, President, Pioneering Medicines, and Executive Partner, Flagship Pioneering. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.